| Zacks Company Profile for Zoetis Inc. (ZTS : NYSE) |
|
|
| |
| • Company Description |
| Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Number of Employees: 13,800 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $158.80 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 2,714,451 shares |
| Shares Outstanding: 445.21 (millions) |
| Market Capitalization: $70,699.04 (millions) |
| Beta: 0.91 |
| 52 Week High: $200.33 |
| 52 Week Low: $139.70 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-5.94% |
-9.46% |
| 12 Week |
6.81% |
-10.15% |
| Year To Date |
-2.53% |
-8.72% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Kristin C. Peck - Chief Executive Officer and Director
Michael B. McCallister - Chairman and Director
Wetteny Joseph - Executive Vice President and Chief Financial Offic
Paul M. Bisaro - Director
Vanessa Broadhurst - Director
|
|
Peer Information
Zoetis Inc. (GSAC)
Zoetis Inc. (CASI)
Zoetis Inc. (ALCD.)
Zoetis Inc. (OMNN)
Zoetis Inc. (CGPI.)
Zoetis Inc. (CATX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 98978V103
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/05/25
|
|
Share - Related Items
Shares Outstanding: 445.21
Most Recent Split Date: (:1)
Beta: 0.91
Market Capitalization: $70,699.04 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 1.26% |
| Current Fiscal Quarter EPS Consensus Estimate: $1.67 |
Indicated Annual Dividend: $2.00 |
| Current Fiscal Year EPS Consensus Estimate: $6.26 |
Payout Ratio: 0.33 |
| Number of Estimates in the Fiscal Year Consensus: 10.00 |
Change In Payout Ratio: 0.07 |
| Estmated Long-Term EPS Growth Rate: 9.64% |
Last Dividend Paid: 04/21/2025 - $0.50 |
| Next EPS Report Date: 08/05/25 |
|
|
|
| |
